Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionStapled peptide that hits up to 5 different targets including B cell lymphoma 2 (Bcl-2), Bcl-XL, myeloid leukemia cell differentiation protein (Mcl-l), Bcl-2-associated X protein (BAX) and Bcl-2 homologous antagonist/killer (BAK)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today